Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1105 entries
Sorted by: Best Match Show Resources per page
Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice.

Clinical and molecular allergy : CMA

Petrarca C, Clemente E, Amato V, Gatta A, Cortese S, Lamolinara A, Rossi C, Zanotta S, Mistrello G, Paganelli R, Di Gioacchino M.
PMID: 27499704
Clin Mol Allergy. 2016 Aug 05;14:7. doi: 10.1186/s12948-016-0044-1. eCollection 2016.

BACKGROUND: Airborne allergens can induce an immunological chronic disease characterized by airway hyper responsiveness and inflammation, mediated by exaggerated Th2 immune response. Allergen-specific immunotherapy (AIT) is effective for treating this condition because it is able to modify its natural...

Cite
Petrarca C, Clemente E, Amato V, et al. Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice. Clin Mol Allergy. 2016;14:7doi: 10.1186/s12948-016-0044-1.
Petrarca, C., Clemente, E., Amato, V., Gatta, A., Cortese, S., Lamolinara, A., Rossi, C., Zanotta, S., Mistrello, G., Paganelli, R., & Di Gioacchino, M. (2016). Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice. Clinical and molecular allergy : CMA, 147. https://doi.org/10.1186/s12948-016-0044-1
Petrarca, Claudia, et al. "Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice." Clinical and molecular allergy : CMA vol. 14 (2016): 7. doi: https://doi.org/10.1186/s12948-016-0044-1
Petrarca C, Clemente E, Amato V, Gatta A, Cortese S, Lamolinara A, Rossi C, Zanotta S, Mistrello G, Paganelli R, Di Gioacchino M. Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice. Clin Mol Allergy. 2016 Aug 05;14:7. doi: 10.1186/s12948-016-0044-1. eCollection 2016. PMID: 27499704; PMCID: PMC4975903.
Copy Download .nbib Format: NLM
CRISPR-Cas Systems Features and the Gene-Reservoir Role of Coagulase-Negative Staphylococci.

Frontiers in microbiology

Rossi CC, Souza-Silva T, Araújo-Alves AV, Giambiagi-deMarval M.
PMID: 28861060
Front Microbiol. 2017 Aug 15;8:1545. doi: 10.3389/fmicb.2017.01545. eCollection 2017.

The claimed role of gene reservoir of coagulase-negative staphylococci (CoNS) could be contradicted by estimates that CRISPR/Cas systems are found in the genomes of 40-50% of bacteria, as these systems interfere with plasmid uptake in staphylococci. To further correlate...

Cite
Rossi CC, Souza-Silva T, Araújo-Alves AV, et al. CRISPR-Cas Systems Features and the Gene-Reservoir Role of Coagulase-Negative Staphylococci. Front Microbiol. 2017;8:1545doi: 10.3389/fmicb.2017.01545.
Rossi, C. C., Souza-Silva, T., Araújo-Alves, A. V., & Giambiagi-deMarval, M. (2017). CRISPR-Cas Systems Features and the Gene-Reservoir Role of Coagulase-Negative Staphylococci. Frontiers in microbiology, 81545. https://doi.org/10.3389/fmicb.2017.01545
Rossi, Ciro C, et al. "CRISPR-Cas Systems Features and the Gene-Reservoir Role of Coagulase-Negative Staphylococci." Frontiers in microbiology vol. 8 (2017): 1545. doi: https://doi.org/10.3389/fmicb.2017.01545
Rossi CC, Souza-Silva T, Araújo-Alves AV, Giambiagi-deMarval M. CRISPR-Cas Systems Features and the Gene-Reservoir Role of Coagulase-Negative Staphylococci. Front Microbiol. 2017 Aug 15;8:1545. doi: 10.3389/fmicb.2017.01545. eCollection 2017. PMID: 28861060; PMCID: PMC5559504.
Copy Download .nbib Format: NLM
A first-principle calculation of the XANES spectrum of Cu(2+) in water.

The Journal of chemical physics

La Penna G, Minicozzi V, Morante S, Rossi GC, Stellato F.
PMID: 26429025
J Chem Phys. 2015 Sep 28;143(12):124508. doi: 10.1063/1.4931808.

The progress in high performance computing we are witnessing today offers the possibility of accurate electron density calculations of systems in realistic physico-chemical conditions. In this paper, we present a strategy aimed at performing a first-principle computation of the...

Cite
La Penna G, Minicozzi V, Morante S, et al. A first-principle calculation of the XANES spectrum of Cu(2+) in water. J Chem Phys. 2015;143(12):124508doi: 10.1063/1.4931808.
La Penna, G., Minicozzi, V., Morante, S., Rossi, G. C., & Stellato, F. (2015). A first-principle calculation of the XANES spectrum of Cu(2+) in water. The Journal of chemical physics, 143(12), 124508. https://doi.org/10.1063/1.4931808
La Penna, G, et al. "A first-principle calculation of the XANES spectrum of Cu(2+) in water." The Journal of chemical physics vol. 143,12 (2015): 124508. doi: https://doi.org/10.1063/1.4931808
La Penna G, Minicozzi V, Morante S, Rossi GC, Stellato F. A first-principle calculation of the XANES spectrum of Cu(2+) in water. J Chem Phys. 2015 Sep 28;143(12):124508. doi: 10.1063/1.4931808. PMID: 26429025.
Copy Download .nbib Format: NLM
Development and testing of an in-stream phosphorus cycling model for the soil and water assessment tool.

Journal of environmental quality

White MJ, Storm DE, Mittelstet A, Busteed PR, Haggard BE, Rossi C.
PMID: 25602554
J Environ Qual. 2014 Jan;43(1):215-23. doi: 10.2134/jeq2011.0348.

The Soil and Water Assessment Tool is widely used to predict the fate and transport of phosphorus (P) from the landscape through streams and rivers. The current in-stream P submodel may not be suitable for many stream systems, particularly...

Cite
White MJ, Storm DE, Mittelstet A, et al. Development and testing of an in-stream phosphorus cycling model for the soil and water assessment tool. J Environ Qual. 2014;43(1):215-23doi: 10.2134/jeq2011.0348.
White, M. J., Storm, D. E., Mittelstet, A., Busteed, P. R., Haggard, B. E., & Rossi, C. (2014). Development and testing of an in-stream phosphorus cycling model for the soil and water assessment tool. Journal of environmental quality, 43(1), 215-23. https://doi.org/10.2134/jeq2011.0348
White, Michael J, et al. "Development and testing of an in-stream phosphorus cycling model for the soil and water assessment tool." Journal of environmental quality vol. 43,1 (2014): 215-23. doi: https://doi.org/10.2134/jeq2011.0348
White MJ, Storm DE, Mittelstet A, Busteed PR, Haggard BE, Rossi C. Development and testing of an in-stream phosphorus cycling model for the soil and water assessment tool. J Environ Qual. 2014 Jan;43(1):215-23. doi: 10.2134/jeq2011.0348. PMID: 25602554.
Copy Download .nbib Format: NLM
Anaplastic lymphoma kinase (ALK) gene alteration in signet ring cell carcinoma of the gastrointestinal tract.

Therapeutic advances in medical oncology

Alese OB, El-Rayes BF, Sica G, Zhang G, Alexis D, La Rosa FG, Varella-Garcia M, Chen Z, Rossi MR, Adsay NV, Khuri FR, Owonikoko TK.
PMID: 25755678
Ther Adv Med Oncol. 2015 Mar;7(2):56-62. doi: 10.1177/1758834014567117.

OBJECTIVES: ALK-EML4 translocation is an established driver aberration in non-small cell lung cancer (NSCLC), with reported predilection for cases with signet ring histology. We assessed the presence of anaplastic lymphoma kinase (ALK) gene rearrangements in signet ring cancers arising...

Cite
Alese OB, El-Rayes BF, Sica G, et al. Anaplastic lymphoma kinase (ALK) gene alteration in signet ring cell carcinoma of the gastrointestinal tract. Ther Adv Med Oncol. 2015;7(2):56-62doi: 10.1177/1758834014567117.
Alese, O. B., El-Rayes, B. F., Sica, G., Zhang, G., Alexis, D., La Rosa, F. G., Varella-Garcia, M., Chen, Z., Rossi, M. R., Adsay, N. V., Khuri, F. R., & Owonikoko, T. K. (2015). Anaplastic lymphoma kinase (ALK) gene alteration in signet ring cell carcinoma of the gastrointestinal tract. Therapeutic advances in medical oncology, 7(2), 56-62. https://doi.org/10.1177/1758834014567117
Alese, Olatunji B, et al. "Anaplastic lymphoma kinase (ALK) gene alteration in signet ring cell carcinoma of the gastrointestinal tract." Therapeutic advances in medical oncology vol. 7,2 (2015): 56-62. doi: https://doi.org/10.1177/1758834014567117
Alese OB, El-Rayes BF, Sica G, Zhang G, Alexis D, La Rosa FG, Varella-Garcia M, Chen Z, Rossi MR, Adsay NV, Khuri FR, Owonikoko TK. Anaplastic lymphoma kinase (ALK) gene alteration in signet ring cell carcinoma of the gastrointestinal tract. Ther Adv Med Oncol. 2015 Mar;7(2):56-62. doi: 10.1177/1758834014567117. PMID: 25755678; PMCID: PMC4346214.
Copy Download .nbib Format: NLM
The Architecture of Chemical Alternatives Assessment.

Risk analysis : an official publication of the Society for Risk Analysis

Geiser K, Tickner J, Edwards S, Rossi M.
PMID: 26630442
Risk Anal. 2015 Dec;35(12):2152-61. doi: 10.1111/risa.12507. Epub 2015 Dec 02.

Chemical alternatives assessment is a method rapidly developing for use by businesses, governments, and nongovernment organizations seeking to substitute chemicals of concern in production processes and products. Chemical alternatives assessment is defined as a process for identifying, comparing, and...

Cite
Geiser K, Tickner J, Edwards S, et al. The Architecture of Chemical Alternatives Assessment. Risk Anal. 2015;35(12):2152-61doi: 10.1111/risa.12507.
Geiser, K., Tickner, J., Edwards, S., & Rossi, M. (2015). The Architecture of Chemical Alternatives Assessment. Risk analysis : an official publication of the Society for Risk Analysis, 35(12), 2152-61. https://doi.org/10.1111/risa.12507
Geiser, Kenneth, et al. "The Architecture of Chemical Alternatives Assessment." Risk analysis : an official publication of the Society for Risk Analysis vol. 35,12 (2015): 2152-61. doi: https://doi.org/10.1111/risa.12507
Geiser K, Tickner J, Edwards S, Rossi M. The Architecture of Chemical Alternatives Assessment. Risk Anal. 2015 Dec;35(12):2152-61. doi: 10.1111/risa.12507. Epub 2015 Dec 02. PMID: 26630442.
Copy Download .nbib Format: NLM
Developmental myosins: expression patterns and functional significance.

Skeletal muscle

Schiaffino S, Rossi AC, Smerdu V, Leinwand LA, Reggiani C.
PMID: 26180627
Skelet Muscle. 2015 Jul 15;5:22. doi: 10.1186/s13395-015-0046-6. eCollection 2015.

Developing skeletal muscles express unique myosin isoforms, including embryonic and neonatal myosin heavy chains, coded by the myosin heavy chain 3 (MYH3) and MYH8 genes, respectively, and myosin light chain 1 embryonic/atrial, encoded by the myosin light chain 4...

Cite
Schiaffino S, Rossi AC, Smerdu V, et al. Developmental myosins: expression patterns and functional significance. Skelet Muscle. 2015;5:22doi: 10.1186/s13395-015-0046-6.
Schiaffino, S., Rossi, A. C., Smerdu, V., Leinwand, L. A., & Reggiani, C. (2015). Developmental myosins: expression patterns and functional significance. Skeletal muscle, 522. https://doi.org/10.1186/s13395-015-0046-6
Schiaffino, Stefano, et al. "Developmental myosins: expression patterns and functional significance." Skeletal muscle vol. 5 (2015): 22. doi: https://doi.org/10.1186/s13395-015-0046-6
Schiaffino S, Rossi AC, Smerdu V, Leinwand LA, Reggiani C. Developmental myosins: expression patterns and functional significance. Skelet Muscle. 2015 Jul 15;5:22. doi: 10.1186/s13395-015-0046-6. eCollection 2015. PMID: 26180627; PMCID: PMC4502549.
Copy Download .nbib Format: NLM
Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review.

Therapeutics and clinical risk management

Sessa M, Rossi C, Mascolo A, Scavone C, di Mauro G, Grassi R, Sportiello L, Cappabianca S, Rafaniello C.
PMID: 29123405
Ther Clin Risk Manag. 2017 Oct 24;13:1463-1478. doi: 10.2147/TCRM.S144418. eCollection 2017.

BACKGROUND AND OBJECTIVE: The use of contrast media in Italy has exponentially increased in the past 3 decades. However, it is unknown whether there has been an increase in clinical research evaluating the risks associated with contrast media usage,...

Cite
Sessa M, Rossi C, Mascolo A, et al. Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review. Ther Clin Risk Manag. 2017;13:1463-1478doi: 10.2147/TCRM.S144418.
Sessa, M., Rossi, C., Mascolo, A., Scavone, C., di Mauro, G., Grassi, R., Sportiello, L., Cappabianca, S., & Rafaniello, C. (2017). Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review. Therapeutics and clinical risk management, 131463-1478. https://doi.org/10.2147/TCRM.S144418
Sessa, Maurizio, et al. "Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review." Therapeutics and clinical risk management vol. 13 (2017): 1463-1478. doi: https://doi.org/10.2147/TCRM.S144418
Sessa M, Rossi C, Mascolo A, Scavone C, di Mauro G, Grassi R, Sportiello L, Cappabianca S, Rafaniello C. Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review. Ther Clin Risk Manag. 2017 Oct 24;13:1463-1478. doi: 10.2147/TCRM.S144418. eCollection 2017. PMID: 29123405; PMCID: PMC5661489.
Copy Download .nbib Format: NLM
Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients.

Diabetes research and clinical practice

Giorda CB, Forlani G, Manti R, Mazzotti A, De Cosmo S, Rossi MC, Nicolucci A, Di Bartolo P, Ceriello A, Guida P, Tartaglino B, Russo G.
PMID: 29097288
Diabetes Res Clin Pract. 2018 Jan;135:65-72. doi: 10.1016/j.diabres.2017.10.023. Epub 2017 Oct 31.

AIMS: The prevalence and progression of hepatic fibrosis and its correlated factors in type 2 diabetes (T2DM) are poorly known. We aimed to define the percentage of T2DM patients who progress to fibrosis and the factors associated with disease...

Cite
Giorda CB, Forlani G, Manti R, et al. Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients. Diabetes Res Clin Pract. 2017;135:65-72doi: 10.1016/j.diabres.2017.10.023.
Giorda, C. B., Forlani, G., Manti, R., Mazzotti, A., De Cosmo, S., Rossi, M. C., Nicolucci, A., Di Bartolo, P., Ceriello, A., Guida, P., Tartaglino, B., Russo, G. (2018). Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients. Diabetes research and clinical practice, 13565-72. https://doi.org/10.1016/j.diabres.2017.10.023
Giorda, Carlo Bruno, et al. "Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients." Diabetes research and clinical practice vol. 135 (2018): 65-72. doi: https://doi.org/10.1016/j.diabres.2017.10.023
Giorda CB, Forlani G, Manti R, Mazzotti A, De Cosmo S, Rossi MC, Nicolucci A, Di Bartolo P, Ceriello A, Guida P, Tartaglino B, Russo G. Trend over time in hepatic fibrosis score in a cohort of type 2 diabetes patients. Diabetes Res Clin Pract. 2018 Jan;135:65-72. doi: 10.1016/j.diabres.2017.10.023. Epub 2017 Oct 31. PMID: 29097288.
Copy Download .nbib Format: NLM
Pharmacological Enhancement of Mutated α-Glucosidase Activity in Fibroblasts from Patients with Pompe Disease.

Molecular therapy : the journal of the American Society of Gene Therapy

Parenti G, Zuppaldi A, Gabriela Pittis M, Rosaria Tuzzi M, Annunziata I, Meroni G, Porto C, Donaudy F, Rossi B, Rossi M, Filocamo M, Donati A, Bembi B, Ballabio A, Andria G.
PMID: 28182897
Mol Ther. 2007 Mar;15(3):508-514. doi: 10.1038/sj.mt.6300074. Epub 2016 Dec 08.

We investigated the use of pharmacological chaperones for the therapy of Pompe disease, a metabolic myopathy due to mutations of the gene encoding the lysosomal hydrolase α-glucosidase (GAA) and characterized by generalized glycogen storage in cardiac and skeletal muscle....

Cite
Parenti G, Zuppaldi A, Gabriela Pittis M, et al. Pharmacological Enhancement of Mutated α-Glucosidase Activity in Fibroblasts from Patients with Pompe Disease. Mol Ther. 2016;15(3):508-514doi: 10.1038/sj.mt.6300074.
Parenti, G., Zuppaldi, A., Gabriela Pittis, M., Rosaria Tuzzi, M., Annunziata, I., Meroni, G., Porto, C., Donaudy, F., Rossi, B., Rossi, M., Filocamo, M., Donati, A., Bembi, B., Ballabio, A., & Andria, G. (2007). Pharmacological Enhancement of Mutated α-Glucosidase Activity in Fibroblasts from Patients with Pompe Disease. Molecular therapy : the journal of the American Society of Gene Therapy, 15(3), 508-514. https://doi.org/10.1038/sj.mt.6300074
Parenti, Giancarlo, et al. "Pharmacological Enhancement of Mutated α-Glucosidase Activity in Fibroblasts from Patients with Pompe Disease." Molecular therapy : the journal of the American Society of Gene Therapy vol. 15,3 (2007): 508-514. doi: https://doi.org/10.1038/sj.mt.6300074
Parenti G, Zuppaldi A, Gabriela Pittis M, Rosaria Tuzzi M, Annunziata I, Meroni G, Porto C, Donaudy F, Rossi B, Rossi M, Filocamo M, Donati A, Bembi B, Ballabio A, Andria G. Pharmacological Enhancement of Mutated α-Glucosidase Activity in Fibroblasts from Patients with Pompe Disease. Mol Ther. 2007 Mar;15(3):508-514. doi: 10.1038/sj.mt.6300074. Epub 2016 Dec 08. PMID: 28182897.
Copy Download .nbib Format: NLM
Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study.

Diabetes therapy : research, treatment and education of diabetes and related disorders

Simioni N, Filippi A, Scardapane M, Nicolucci A, Rossi MC, Frison V.
PMID: 28585180
Diabetes Ther. 2017 Aug;8(4):941-946. doi: 10.1007/s13300-017-0271-6. Epub 2017 Jun 05.

INTRODUCTION: To assess the efficacy and safety of insulin degludec administered in a basal-bolus regimen according to the GesTIO protocol in noncritical hospitalized patients with T1DM and T2DM.METHODS: Mean blood glucose levels (BG) and their standard deviations (SD) at...

Cite
Simioni N, Filippi A, Scardapane M, et al. Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study. Diabetes Ther. 2017;8(4):941-946doi: 10.1007/s13300-017-0271-6.
Simioni, N., Filippi, A., Scardapane, M., Nicolucci, A., Rossi, M. C., & Frison, V. (2017). Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study. Diabetes therapy : research, treatment and education of diabetes and related disorders, 8(4), 941-946. https://doi.org/10.1007/s13300-017-0271-6
Simioni, Natalino, et al. "Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study." Diabetes therapy : research, treatment and education of diabetes and related disorders vol. 8,4 (2017): 941-946. doi: https://doi.org/10.1007/s13300-017-0271-6
Simioni N, Filippi A, Scardapane M, Nicolucci A, Rossi MC, Frison V. Efficacy and Safety of Insulin Degludec for Hyperglycemia Management in Noncritical Hospitalized Patients with Diabetes: An Observational Study. Diabetes Ther. 2017 Aug;8(4):941-946. doi: 10.1007/s13300-017-0271-6. Epub 2017 Jun 05. PMID: 28585180; PMCID: PMC5544608.
Copy Download .nbib Format: NLM
Elucidation of the genetic architecture of self-incompatibility in olive: Evolutionary consequences and perspectives for orchard management.

Evolutionary applications

Saumitou-Laprade P, Vernet P, Vekemans X, Billiard S, Gallina S, Essalouh L, Mhaïs A, Moukhli A, El Bakkali A, Barcaccia G, Alagna F, Mariotti R, Cultrera NGM, Pandolfi S, Rossi M, Khadari B, Baldoni L.
PMID: 29151878
Evol Appl. 2017 May 20;10(9):867-880. doi: 10.1111/eva.12457. eCollection 2017 Oct.

The olive (

Cite
Saumitou-Laprade P, Vernet P, Vekemans X, et al. Elucidation of the genetic architecture of self-incompatibility in olive: Evolutionary consequences and perspectives for orchard management. Evol Appl. 2017;10(9):867-880doi: 10.1111/eva.12457.
Saumitou-Laprade, P., Vernet, P., Vekemans, X., Billiard, S., Gallina, S., Essalouh, L., Mhaïs, A., Moukhli, A., El Bakkali, A., Barcaccia, G., Alagna, F., Mariotti, R., Cultrera, N. G. M., Pandolfi, S., Rossi, M., Khadari, B., & Baldoni, L. (2017). Elucidation of the genetic architecture of self-incompatibility in olive: Evolutionary consequences and perspectives for orchard management. Evolutionary applications, 10(9), 867-880. https://doi.org/10.1111/eva.12457
Saumitou-Laprade, Pierre, et al. "Elucidation of the genetic architecture of self-incompatibility in olive: Evolutionary consequences and perspectives for orchard management." Evolutionary applications vol. 10,9 (2017): 867-880. doi: https://doi.org/10.1111/eva.12457
Saumitou-Laprade P, Vernet P, Vekemans X, Billiard S, Gallina S, Essalouh L, Mhaïs A, Moukhli A, El Bakkali A, Barcaccia G, Alagna F, Mariotti R, Cultrera NGM, Pandolfi S, Rossi M, Khadari B, Baldoni L. Elucidation of the genetic architecture of self-incompatibility in olive: Evolutionary consequences and perspectives for orchard management. Evol Appl. 2017 May 20;10(9):867-880. doi: 10.1111/eva.12457. eCollection 2017 Oct. PMID: 29151878; PMCID: PMC5680433.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1105 entries